Abstract: An adipose tissue (AT) transfer system includes, on the aspiration side, an aspiration cannula, an aspiration pump, a container, and flexible tubing connecting the aspiration cannula to the container. On the reinjection side, the system includes a reinjection cannula, flexible tubing connecting the inlet of the reinjection cannula to the container, and a reinjection pump imposing positive-displacement pumping action on the flexible tubing and causing movement of AT in a continuous or pulsed mode. The aspiration pump operates to continually supply harvested AT to the second flexible tubing while the reinjection pumps causes continuous or pulsed deposition of the AT at the injection site. To ensure that internal pressure and/or flow of the AT through a channel of delivery of the AT to the reinjection site does not exceed a predetermined value, the system contains an external pressure sensor configured to measure such internal pressure in absence of a part that is in direct contact with the AT.

Abstract: Some embodiments have a pump assembly mounted to or supported by a dressing for reduced pressure wound therapy. The dressing can have visual pressure, saturation, and/or temperature sensors to provide a visual indication of the level of pressure, saturation, and/or temperature within the dressing. Additionally, the pump assembly can have a pressure sensor in communication with the flow pathway through the pump, and at least one switch or button supported by the housing, the at least one switch or button being accessible to a user and being in communication with the controller. The pump assembly can have a controller supported within or by the housing, the controller being configured to control an operation of the pump. The pump can be configured to be sterilized following the assembly of the pump such that all of the components of the pump have been sterilized.

Abstract: Fluid collection systems and methods are disclosed which may utilize suction to draw fluids into containers for storage and eventual disposal. The system may utilize rigid or semi-rigid canisters to provide a chamber in which fluids may be collected under negative pressure, stored, and transported. The system may utilize disposable or reusable flexible, semi-rigid, or rigid liners for isolating fluid and liquid waste from the walls of the canister. In various embodiments, either a single canister assembly or multiple canister assemblies are mounted to a manifold, the manifold being configured to support each canister assembly and/or provide a connection to a source of suction for each canister assembly.

Abstract: A surgical tissue therapy device includes a sealant layer and a collection chamber. The sealant layer functions so as to create a sealed enclosure, or space between it and the surface of a patient, by forming an airtight seal around a surgical area of skin trauma. The closed incision tissue therapy device also comprises a collection chamber, which may comprise an elongate tubular chamber with a plurality of longitudinally spaced openings. The collection chamber may be configured to be in fluid communication with the sealant layer and the area of skin trauma and functions as to distribute the negative pressure applied to a surgically closed area of skin trauma. Preferably, the pressure under the sealant layer is reduced by expanding the volume of the enclosure space and thereby decreasing the density of air molecules under the sealant layer. The collection material may comprise a material and/or a configuration that permits length changes based upon the length of the corresponding surgical wound or incision.

Abstract: Methods and systems for reducing bacterial contamination of platelets are disclosed. The methods and systems disclosed herein provide for the processing of a pre-determined volume of whole blood so as to reduce the risk that platelets separated and collected from the whole blood have a reduced risk of bacterial contamination.

Abstract: In one embodiment, the present invention is a method of positioning in a mammalian heart of a patient a blood pump including an inflow cannula, a pump housing and an outflow cannula, the method including forming an incision in a low-pressure location on the heart wall; passing the outflow cannula of the blood pump through the incision and into a left ventricle of a heart; positioning a tip of a guidewire into an aorta, distal to an aortic valve; advancing the tip through the aortic valve and into the left ventricle; connecting the tip to the outflow cannula; pulling the blood pump with the guidewire to advance at least a portion of the outflow cannula through the aortic valve and into the aorta; securing the blood pump to the heart, the aorta, or both; disconnecting the tip from the blood pump; and removing the guidewire from the patient.

Abstract: An implantable heart assist system includes a compressible pumping chamber including an inlet conduit configured to be placed in fluid connection with the descending thoracic aorta and an outlet conduit configured to be placed in fluid connection with the thoracic aorta; and a pump system comprising a first rigid member, a second rigid member spaced from the first rigid member so that at least a portion of the pumping chamber may be positioned between the first rigid member and the second rigid member, a drive system configured to cause the second rigid member to move toward the first rigid member or away from the first rigid member, and a controller in operative connection with the drive system and controlling the motor, wherein movement of the second rigid member toward the first rigid member results in compression of the pumping chamber and movement of the second rigid member away from the first rigid member causes expansion of the pumping chamber.

Abstract: The present invention relates to devices, systems, and methods for controlling the concentration of potassium in dialysate in a closed loop potassium control system. The devices, systems, and methods can be compatible with any dialysis system including sorbent-based dialysis systems, single pass dialysis systems, or other multi-pass dialysis systems. The systems can use closed loop potassium control over potassium concentration in the dialysate to reduce the probability of patient arrhythmias. The potassium concentration can be controlled and personalized to a patient using certain predetermined patient parameters. Related systems, algorithms, and control systems are contemplated for optimizing the potassium concentration in the dialysate.

Abstract: In a blood purification device containing a blood purifier, a blood circuit, a blood pump, and a dialysate line having a fresh dialysate supply line and a used dialysate discharge line, a pair of plunger pumps are disposed in the dialysate line. The pair of plunger pumps are synchronized so that delivery of a fresh dialysate from one plunger pump and suction of a used dialysate into the other plunger pump simultaneously occur and the stroke of at least one of the pair of plunger pumps is made variable.

Abstract: A device for extracorporeal blood treatment comprising at least a first concentrate connection which is set up to feed at least a first concentrate into the device for extracorporeal blood treatment as the basis for generating a dialysate; at least a second concentrate connection which is configured to feed at least a second concentrate into the device for extracorporeal blood treatment as the basis for generating a dialysate; wherein the device for extracorporeal blood treatment is configured to switch over from supplying the at least first concentrate to supplying the at least second concentrate at a predetermined time or after a predetermined period of time during an ongoing blood treatment.

Abstract: The invention relates to a method and to a device for supplying a dialysis device with dialysate, and to a dialysis device comprising a device for supplying the dialysis device with dialysate. For producing dialysate, a container 13 filled with a pulverulent dialysate concentrate K is provided, the amount of dialysate concentrate in the container being set in such a way that an amount of dialysate sufficient for a specified number of dialysis treatments can be produced using the dialysate concentrate. The method according to the invention and the device according to the invention make it possible to align the amount K2 of concentrate in the container 13 and the planned consumption amount, which is dependent on the prescription from the doctor and the treatment parameters established by the machine. After the individual dialysis treatments have been carried out, it is continuously monitored whether the amount of concentrate is sufficient.

Abstract: A method for delivering a target volume of fluid to a destination is provided. The method includes delivering a first volume of fluid to the destination in increments each having approximately a first incremental volume, the first volume of fluid being less than the target volume and delivering a second volume of fluid to the destination in increments each having approximately a second incremental volume, the second incremental volume being less than the first incremental volume, such that the sum of the first volume and the second volume is approximately equal to the target volume.

Abstract: The present invention relates to a method and apparatus for the isolation, modification and re-administration of a molecule or biomolecule, or a class of biomolecules, from the body fluid of a mammal via an extracorporeal closed circuit device. The device is able to capture and modify the biomolecule by the covalent or non-covalent attachment of a secondary molecule or protein, by cross-linking the captured molecule, or by altering the structure of the molecule (for example, by deglycosylation, peptide cleavage, or aggregation). The apparatus can be used to return the modified molecule or biomolecule to the mammalian subject. The device and methods may be utilized for the patient-specific diagnosis and/or treatment of a disease state which presents an associated molecule or protein in plasma or any other fluidized physiological system.

Abstract: The present disclosure concerns a method for preparing an extracorporeal blood circuit for its use in a blood treatment of a patient, which treatment is carried out using a blood treatment apparatus and using a blood treatment device, which comprises a blood chamber and a dialysate chamber partitioned off therefrom by a membrane, The method comprising: filling the extracorporeal blood circuit using a priming solution, wherein the priming solution comprises citrate, or filling of the extracorporeal blood circuit using a priming solution and using a citrate solution. The invention further comprises devices suitable for carrying out the method.

Abstract: A cardioplegic agent delivery system comprises a syringe pump for providing cardioplegic agent into a carrier fluid of a perfusion system, a flow sensor for sensing a flow of the carrier fluid, and an interlock responsive to the flow sensor. The interlock prevents operation of the syringe pump in the absence of carrier fluid flow sensed by the flow sensor. This provides increased safety in a cardioplegic agent delivery system.

Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.

Abstract: A system for preparing an injection includes a first container with a first cavity and a rigid outer wall and two ends, a movable stopper being provided on one side of the first cavity, which sealingly closes this cavity and is displaceable inside the first container and comprising a second container, which encloses a second cavity, one container comprising a first substance, and the other container comprising a second substance. The second container comprises an at least regionally elastic wall and in this way has a variable volume. The second container is designed such that a pressure can be built inside the second container by way of the at least regionally elastic wall. The second container is a tube.

Abstract: Disclosed is a colonic irrigator capable of cleansing the inside of the large intestine and removing impacted feces remaining inside the large intestine by spraying a cleansing solution into the large intestine. The colonic irrigator includes a cleansing body 10 having a laid down egg shape, having a spray hole 12 formed at a lifted portion 11 provided on the upper part thereof and having a cleansing solution channel 13 formed therein to communicate with the spray hole 12, and a connector 20 which has a screw part 21 formed at one side thereof so as to be connected to a shower hose 40, is bent at 90 degrees such that the other side is connected to the lower part of the cleansing body 10, and has a cleansing solution channel 23 formed therein to communicate with the cleansing solution channel 13 of the cleansing body 10, where the cleansing body 10 and the connector 20 are integrated.

Abstract: This document provides devices, systems, and methods for treating patients with wounds. For example, this document provides a multi-lumen tubular device that can deliver wound irrigation, wound suction, and medicinal treatment through the lumens of the tubular device.

Abstract: An implantable and retrievable medical device is provided. The device may be implanted in and extracted from a patient and the device is adapted to house and deliver donor cells or other drugs. The device comprises a hollow core having a volume for receiving cells and a plurality of layers surrounding the core. The layers comprise various materials suitable for enhancing immunoprotection and for promoting vascular growth into the device.

Abstract: A medical injector including at least one syringe port for engaging at least one syringe and having a locking mechanism. The locking mechanism enables the syringe to self-align with the syringe port for locking engagement upon insertion of the syringe into the syringe port and to axially eject the syringe from the port upon rotational disengagement of the syringe from the port.

Abstract: An object of the present invention is to provide an infusion preparation in which the Maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. The present invention provides an infusion preparation containing two chambers separated by a partition that can be communicably opened, wherein a first chamber contains a first-chamber infusion containing a sugar and a fat emulsion, a second chamber contains a second-chamber infusion containing an amino acid and an electrolyte, the first-chamber infusion is substantially free of potassium, and has a relative osmotic pressure of 2.0 to 3.

Abstract: The invention relates to a device and a method for connecting a vial [1] to a container or to a fluid line and transferring the contents of a vial [1] to a container or to a fluid line, wherein the device has a first holder [4] which is suitable for accommodating a connecting device [8], a second holder [5] which is suitable for accommodating a vial [1], an actuating means [7] and a connecting device [8] which consists of an annular housing [13], an inside part [12] having at least one puncture device [14] and a tube connection [16], wherein the annular housing [13] of the connecting device [8] can be constructed to be rotatable about the inside part [12] in the function of a valve, so that by rotation of the housing [13] the flow paths of the connecting device [8] can be opened and closed.

Abstract: Embodiments may include a method of delivering a drug. The method may include removing or releasing a structure from a patch-pump assembly. The patch-pump assembly may include a sealed prefilled drug-reservoir, a fluid passageway, a cannula-containing assembly, and a penetrator. The method may also include penetrating the sealed prefilled drug-reservoir containing the drug to establish fluid communication between the sealed prefilled drug-reservoir and a fluid passageway by removing or releasing the structure. The method may further include flowing the drug from the prefilled drug-reservoir to the fluid passageway. In addition, the method may include flowing the drug from the fluid passageway to a cannula-containing assembly. Furthermore, the method may include delivering the drug subcutaneously to a subject using the cannula-containing assembly.

Abstract: In one aspect, containment devices are provided that include a microchip element having one or more containment reservoirs that are configured to be electrically activated to open; an electronic printed circuit board (PCB) or a silicon substrate positioned adjacent to the microchip element; one or more electronic components associated with the microchip element or the PCB/silicon substrate; and a first inductive coupling device associated with the microchip element or the PCB/silicon substrate, wherein the first inductive coupling device is in operable communication with the one or more electronic components. In another aspect, implantable drug delivery devices are provided that include a body housing at least one drug payload for actively controlled release, wherein the ratio of the volume of the at least one drug payload to the total volume of the implantable drug delivery device is from about 75 ?L/cc to about 150 ?L/cc.

Abstract: Posture-responsive therapy is delivered by the medical system based on posture state input from only one of multiple posture sensors at any given time. An example implantable medical system includes a first posture sensor and a second sensor. A processor controls therapy delivery to the patient based on at least one of a patient posture state or a patient activity level determined based on input from only one of the first or second posture sensors. In some examples, one of multiple posture sensors of an implantable posture-responsive medical system is used to automatically reorient another posture sensor (of the system), which has become disoriented. The disoriented posture sensor may be automatically reoriented for one or more posture states at a time.

Abstract: A dropping rate measuring device for measuring a flow rate of liquid droplets which grow on a lower end of a nozzle and intermittently drop from the lower end of the nozzle includes an imaging unit that images a growing liquid droplet which is growing on the lower end of the nozzle at a plurality of time points and acquires a plurality of pieces of image data of the growing liquid droplet, and a data processor that calculates the flow rate by analyzing the plurality of pieces of image data acquired by the imaging unit.

Abstract: The present subject matter includes a cannulated delivery device made of an adapter configured to connect to a syringe; a delivery device tip configured to connect to a dosing chamber; an internal chamber of the cannulated delivery device connecting the adapter and to the delivery device tip, and the internal chamber defining a dose pathway and a system and method of use of the device to increase dosage delivery to a patient while maintaining a sterile fluid pathway.

Abstract: A drive mechanism of an injection device for setting and dispensing of a dose of a medicament includes a body accommodating a cartridge filled with a medicament, an insert axially displaceable inside the body between a proximal operating position and a distal reset position, a piston rod to operably engage with a piston of the cartridge, a drive sleeve rotationally coupled with the piston rod and is rotationally lockable to the body for setting of a dose and rotationally releasable from the body for dispensing of a dose, respectively. The drive sleeve is axially displaceable relative to the body from a proximal operating position into a distal reset position through an axial connection of the insert and the drive sleeve, where the drive sleeve is rotationally released from the body when in the distal reset position.

Abstract: A medicament delivery device is presented having a housing that is arranged to accommodate a medicament container, a drive mechanism capable of, upon activation, act on said medicament container, a communication unit arranged in the housing, a switch operably connectable to the drive mechanism and connected to the communication unit for activating the communication unit when the switch is operated, wherein the switch is operated by the drive mechanism at the end of a dose delivery sequence.

Abstract: An automatic administration instrument includes a syringe and a partition wall in the syringe which partitions the syringe into different rooms for respectively holding plural kinds of drug solutions or a drug and a drug solution. A partition-wall driver displaces the partition wall and an injection needle is connected to the syringe. A body cap attached to the administration instrument body so as to cover the injection needle. The syringe, the partition wall, and the body cap are configured such that displacing the partition wall dissolves or mixes the drug solutions or the drug and the drug solution in a state that the injection needle is covered by the body cap.

Abstract: Methods for operating an injection device that is mated to a mobile device are disclosed. Methods include sensing movements of the injection device and enabling inputs on the mobile device based on the movements of the injection device. Methods also include receiving desired injection parameter values into the mobile device, transmitting signals indicative of injection parameters from the mobile device to the injection device, activating injection of medicament with the injection device in accordance with the signals received from the mobile device, and obtaining data regarding the administered injection from the injection device.

Abstract: The present invention relates to a medicament delivery device comprising a housing (60), which housing is arranged to accommodate a medicament container (62); a drive unit (86) operably arranged to act on said medicament container (62) for expelling a dose of medicament; an activation unit (74) operably connected to said drive unit for activating said drive unit (86); said drive unit (86) comprising an actuation element (84) arranged movable inside the housing (60) from an initial position prior to activation, to a displaced position after activation; at least a first NFC-chip (170, 172) comprising specific information arranged on said actuation element; at least one shielding element (174) arranged to said housing, such as to shield said at least first NFC-chip (170, 172) from being read by an NFC-chip reader when said actuation element (84) is either in the initial position or in the displaced position.

Abstract: The invention relates to an activating mechanism for a medicament delivery device (1), comprising: —an outer body (8), —a cartridge (2) containing a dosage of a medicament and sealed with a sealing element (2.1) that is arranged across an open distal end of the cartridge (2), —a cartridge carrier (4) adapted to hold the cartridge (2), —a needle safety mechanism adapted to hold a double-ended hollow needle (6) and to relatively move along a longitudinal axis (L) with respect to the cartridge (2) and to the outer body (8) to cover or to expose the needle (6), —wherein in an initial position (P1) of the medicament delivery device (1), the double-ended hollow needle (6) is spaced from the cartridge (2) in a distal direction (D), and —wherein when the needle safety mechanism is pressed into the outer body (8), a proximal end of the needle (6) pierces the sealing element (2.1). The invention further relates to a medicament delivery device (1) comprising such an activating mechanism.

Abstract: A needle-free injection device suitable for delivering a therapeutic substance into the intradermal space of a patient. The needle-free injection device includes an injector body defining a syringe end. The device also includes a first handle attached with a hinge to the injector body such that the first handle pivots between an open and a closed position and remains attached to the injector body during an injection, a main spring positioned within the injector body, a return sleeve engaged with the main spring, and a first linkage between the first handle and the return sleeve. The first linkage causes the return sleeve to move away from the syringe end of the injector body when the first handle is moved from the open position to the closed position, thereby compressing the main spring. Needle-free injection systems and methods of operating a needle-free injection device are also disclosed.

Abstract: A needleless syringe comprises a main syringe body which is a main body thereof and which has, in the main body, a sliding movement passage connected to an opening provided on a front end surface of the main body; a holding unit which has an accommodating unit for accommodating an injection objective substance so that the injection objective substance is releasable; and a driver that is configured to apply energy to the holding unit in order to allow the holding unit to slide toward the opening. When the energy is applied by the driver to the holding unit disposed at the initial position, the holding unit slides in the sliding movement passage to abut against the opening at the abutment position, and thus the injection objective substance accommodated in the accommodating unit is discharged via the opening. Accordingly, the high injection performance of the needleless syringe is appropriately exhibited.

Abstract: Apparatus for determining information associated with reflection characteristics of a surface comprising a sensor (60) configured to generate sensor output dependent on an intensity of light incident on the sensor and having a field of view directed at an external surface (57) in use; an illumination source (58) configured to emit light onto the external surface in use; an optically transparent window (61) located such as to allow light to pass from the illumination source to the external surface and to allow light to pass to the sensor from the external surface in use; a light concentrator (66) fixed to or integral with the window, the light concentrator being configured to concentrate at least some light from the illumination source onto the external surface in use such that the concentrated light may be reflected from the external surface onto the sensor via the window; and a processor (40) configured to use the sensor output to determine information associated with reflection characteristics of the extern

Abstract: Apparatus comprising: a sensor configured to generate sensor output dependent on an intensity of light incident on the sensor and having a field of view directed at an external surface in use; an illumination source configured to emit light onto the external surface in use; a window located such as to allow light to pass from the illumination source to the external surface and to allow light to pass to the sensor from the external surface in use; a shield coupled to or integral with the window, the shield being substantially opaque to substantially all wavelengths of light detectable by the sensor and defining an aperture which limits the field of view of the sensor; and a processor configured to use the sensor output to determine information associated with reflection characteristics of the external surface.

Abstract: Disclosed herein is a valve assembly comprising a male luer end portion and a female luer end portion and a passage for the transfer of fluids extending between the male and female luer end portions, valve means movable between a first position, in which the passage is closed, and a second position, in which the passage is open, biasing means for biasing the valve means toward the first position, and actuating means extending into the male luer end portion and coupled to the valve means to actuate the valve means when a female luer end portion of a medical accessory is engaged with the male luer end portion.

Abstract: A power pack assembly for a medicament delivery device, the power pack comprising a plunger rod (64) extending along a longitudinal axis (L) and having a proximal and an opposite distal ends, an actuator (90) provided with a holding element (96) and configured to interact with a corresponding holding element on the plunger rod (64), a first force element (68) arranged to exert a force on the plunger rod; an actuator sleeve mechanism (119) arranged to releasibly lock said holding element (96) in engagement with the corresponding holding element of said plunger rod (64) such as to hold said first force element (68) in a tensioned state.

Abstract: The subject matter described herein relates to a supplementary device for attachment to an injection device, the supplementary device comprising: a first imaging arrangement and a second imaging arrangement each configured to capture an image of a moveable number sleeve of the injection device from different respective angles. The supplementary device also comprises a plurality of light sources and a processor arrangement configured to control operation of the first imaging arrangement and the second imaging arrangement and the plurality of light sources and to receive image data from each of the imaging arrangements, wherein the processor arrangement is configured to combine images captured by the first imaging arrangement and the second imaging arrangement into a single image.

Abstract: The present invention is generally directed to an assembly for a drug delivery device comprising a first threaded member (50, 50?), a second threaded member (40, 60?) with a longitudinal axis and a thread (61), having at least two consecutive portions (62, 63, 64) with different leads. The first threaded member (50, 50?) and the second threaded member (40, 60?) are adapted and arranged to rotate with respect to one another about the longitudinal axis of the second threaded member (40, 60?) during dose setting operation of the assembly, the first threaded member (50, 50?) thereby being axially displaced along the second threaded member (40, 60?) from a start position to an end position with respect to the second threaded member (40, 60?) due to the mechanical cooperation of the first threaded member (50, 50?) with the thread (61).

Abstract: A drug delivery device for selecting and dispensing a number of user variable doses of a medicament. The device comprises a housing, a dose setting element rotatable relative to the housing during dose setting and dose dispensing, a drive member coupled to the dose setting member via a clutch, and a piston rod coupled to the housing and to the drive member. Further, the device further comprises a cartridge holder removably attached to the housing and a reset element, which is axially constrained to the dose setting element, and at least one spring acting on the reset element, such that, if the cartridge holder is detached from the housing, the reset element is axially moved relative to the housing onto a position in which the dose setting element is rotationally constrained to the housing and the drive member is allowed to rotate relative to the housing.

Abstract: The present disclosure relates to a drug delivery device comprising: a housing; a moveable number sleeve disposed within the housing and having numbers printed thereon; and a transparent window occupying an aperture of the housing and covering the number sleeve such that the number sleeve is visible through the transparent window. At least one region of the housing located adjacent to the transparent window is transparent to visible light and is in optical communication with the transparent window.

Abstract: A syringe is provided having a hub with an orifice, first and second barrels having interior surfaces to form respective lumens, a slider, and an optional test indicator. The first and second barrels slideably receive respective first and second plungers for movement therein. The slider is operable to provide a fluidly communicative path between the orifice of the hub and the first and second barrel lumens. The optional test indicator is responsive to at least one characteristic of bodily fluid, the test indicator positioned to be exposed to any bodily fluid drawn into the first barrel lumen and visible from an exterior of the first barrel.

Abstract: The present disclosure is generally directed to a drug delivery device for selecting and dispensing a number of user variable doses of a medicament and to an insert for such a device. The insert comprises a cup-shaped body with a distal end and a proximal end. The body has a sidewall and a tube which extends centrally through the cup-shaped body in a longitudinal direction, thereby defining an annular space between the sidewall and the tube. The annular space is open in the proximal direction for receiving a compression spring. The tube comprises a thread provided at an inner surface of the tube. Further, the tube, the sidewall and/or a second part comprise a clutch feature for rotationally constraining a component part to the insert.

Abstract: An epidural needle assembly including an epidural needle assembly and an injection needle assembly. The injection needle assembly is slidably mounted on the needle of the epidural needle assembly between extended and retracted positions. The injection needle assembly includes an injection hub having an injection needle secured thereto which extends forwardly therefrom. When the injection needle assembly is in its retracted position, the forward end of the injection needle is positioned rearwardly of the forward end of the epidural needle. When the injection needle assembly is in its extended position, the forward end of the injection needle is positioned forwardly of the forward end of the epidural needle. When in its extended position, the injection needle is able to create a hole in the skin of a person or animal to permit the epidural needle to be inserted therein.

Abstract: The present invention relates to a needle cover assembly to be used with a medicament delivery device, wherein said needle cover assembly (10) is disposable and comprises a retainer element (50) connectable to the medicament container holder; a hub (16) having a longitudinal axis and comprising a double pointed injection needle (22) with a proximal needle end (24) and a distal needle end (48), wherein the proximal needle end projects a distance from the hub (16) along the longitudinal axis, and a shield (18) covering at least the proximal needle end and a portion of the hub (16).

Abstract: A device can be used for delivering a dose of a vaccine, medicine, medication, drug, or prescription. For example, this document describes a wearable vaccination device that plays an audible sound or musical tune for distracting or entertaining the patient while an intradermal vaccine is delivered via the patient's skin. The control portion of the wearable vaccination device includes a processing unit, a rhythm producer that produces audible sounds to distract or entertain the patient, and an injection module that provides an intradermal injection using one or more microneedles.

Abstract: A handheld cryoanesthesia or analgesia device for cooling a target area on cutaneous membranes, mucous membranes, and tissue of the mucocutaneous zone having an elongated body and a thermoelectric cooling system disposed within the elongated body. The thermoelectric cooling system is configured to physically contact and thermally couple the target area of the cutaneous membranes, mucous membranes, and tissue of the mucocutaneous zone to induce cryoanesthesia or analgesia. The thermoelectric cooling system includes a thermally-conductive cold tip, a thermally-conductive cooling power concentrator thermally coupled to the cold tip, at least one Peltier unit module thermally coupled to the cooling power concentrator, a heatsink thermally coupled to at least one Peltier unit module, a power source, at least one thermal sensor, and a controller operably outputting a control signal to the Peltier unit module to maintain a predetermined temperature.